Technical Analysis for PRAN - Prana Biotechnology Ltd

Grade Last Price % Change Price Change
grade A 2.1 2.94% 0.06
PRAN closed up 2.94 percent on Friday, March 22, 2019, on 1.61 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical PRAN trend table...

Date Alert Name Type % Chg
Mar 22 Shooting Star Candlestick Bearish 0.00%
Mar 22 Pocket Pivot Bullish Swing Setup 0.00%
Mar 22 Calm After Storm Range Contraction 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Above Upper BB Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 Crossed Above 200 DMA Bullish 2.94%
Mar 21 Crossed Above 20 DMA Bullish 2.94%
Mar 21 180 Bullish Setup Bullish Swing Setup 2.94%
Mar 21 Pocket Pivot Bullish Swing Setup 2.94%

Older signals for PRAN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Prana Biotechnology Limited engages in the research and development of therapeutic drugs for the treatment of neurological disorders in Australia. The company primarily focuses on the Alzheimer‘s, Parkinson‘s, and Huntington‘s diseases, as well as various cancer, age-related macular degeneration and cataract, Motor Neuron, and Creutzfeldt-Jakob diseases. Its development stage product line comprises PBT2, a Phase IIb clinical trial product for the treatment of Alzheimer's disease; and PBT2, a Phase IIa clinical trial product for the treatment of Huntington's disease. The company was formerly known as Prana Corporation Ltd. and changed its name to Prana Biotechnology Limited in January 2000. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.
Health Cancer Clinical Trial Alzheimer's Disease Neurological Disorders Chloroarenes Dementia Macular Degeneration Age Related Macular Degeneration Clinical Trial Product Huntington's Disease Treatment Of Alzheimer's Disease Cataract Senescence Abnormal Psychology Treatment Of Huntington's Disease
Is PRAN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.91
52 Week Low 1.0854
Average Volume 101,500
200-Day Moving Average 1.854
50-Day Moving Average 1.6725
20-Day Moving Average 1.8034
10-Day Moving Average 1.9048
Average True Range 0.2072
ADX 44.08
+DI 46.2042
-DI 10.6978
Chandelier Exit (Long, 3 ATRs ) 2.0984
Chandelier Exit (Short, 3 ATRs ) 2.2216
Upper Bollinger Band 2.0764
Lower Bollinger Band 1.5304
Percent B (%b) 1.04
BandWidth 30.276145
MACD Line 0.0926
MACD Signal Line 0.0729
MACD Histogram 0.0196
Fundamentals Value
Market Cap 3.11 Million
Num Shares 1.48 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -3.18
Price-to-Sales 1.84
Price-to-Book 1.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.70
Resistance 3 (R3) 2.73 2.56 2.60
Resistance 2 (R2) 2.56 2.41 2.55 2.57
Resistance 1 (R1) 2.33 2.31 2.45 2.30 2.53
Pivot Point 2.16 2.16 2.22 2.15 2.16
Support 1 (S1) 1.93 2.01 2.05 1.90 1.67
Support 2 (S2) 1.76 1.91 1.75 1.63
Support 3 (S3) 1.53 1.76 1.60
Support 4 (S4) 1.50